In the univariate analysis, the cumulative incidence of extensive chronic GVHD was significantly higher in patients receiving G‐CSF compared to those not receiving it following BMT (p < .001), but not PBSCT (p = .951) or CBT (p = .102) (Figure S1D–F). This evidence concerns the gene CSF3 and chronic graft versus host disease.